GPC1 has proved its overall diagnostic accuracy in the diagnosis of lung SCC that was comparable to the other well-established p63 IHC marker used in the differential diagnosis of NSCLC differentiating lung SCC from lung ADC. Here, GPC1 is linked to non-small cell lung carcinoma.